President Trump dropped a healthcare bombshell this week.
The Great Healthcare Plan would codify drug pricing deals that give Americans the same low prices other countries pay, send insurance subsidies directly to citizens instead of corporations, and force insurance companies to publicly disclose how much profit they’re skimming and how many claims they deny.
“Instead of putting the needs of big corporations and special interests first, our plan finally puts you first,” Trump said. “The government is going to pay the money directly to you. It goes to you, and then you take the money and buy your own health care.”
That sound you hear is insurance company lobbyists scrambling.
Most-Favored-Nation Pricing
Americans pay more for prescription drugs than anyone else in the world. The same pill that costs $10 in Canada costs $100 here.
Trump’s plan would codify Most-Favored-Nation deals — requiring pharmaceutical companies to sell drugs to Americans at the same prices they charge in other developed countries.
If Pfizer sells a drug for $20 in Germany, Americans get it for $20 too.
The pharmaceutical industry has fought this for decades. They claim it would reduce innovation. What it would actually reduce is their profit margins — which is why they’ve spent billions lobbying against it.
Trump is calling their bluff.
Money Goes to You, Not Insurers
Here’s the most radical part of the plan.
Currently, the government sends billions in subsidy payments directly to insurance companies. Americans never see that money — it goes from Treasury to Aetna and Blue Cross, supposedly to reduce premiums.
Trump’s plan changes the flow: the money goes to citizens, who then choose which plan to buy.
“The government is going to pay the money directly to you. It goes to you, and then you take the money and buy your own health care.”
This is consumer choice in action. Instead of bureaucrats and insurance executives deciding how subsidies are spent, individual Americans make their own decisions.
Insurance companies hate this because it means they have to compete for your business instead of collecting guaranteed government payments.
Transparency Requirements
The plan includes transparency measures that will terrify insurance executives.
Insurance companies would have to prominently post the profits they take out of premiums. No more hiding how much of your payment goes to shareholder returns instead of healthcare.
They’d have to publish the percentage of claims they reject. Americans would finally see which insurers routinely deny coverage versus which ones actually pay claims.
They’d have to post average wait times for routine care. No more discovering your “insurance” means waiting three months for a basic appointment.
Rate and coverage comparisons would be published so consumers can actually shop for the best deal.
This is sunlight as disinfectant. When Americans can see exactly how much insurers profit and how often they deny claims, the worst actors will lose customers.
Healthcare Providers Too
The transparency requirements apply to both sides.
Healthcare providers that accept Medicare or Medicaid would have to post pricing in their place of business. No more surprise bills. No more finding out a procedure costs $50,000 after it’s done.
They’d also have to ensure insurance companies comply with price transparency rules — creating accountability on both ends.
Ending PBM Kickbacks
Pharmacy Benefit Managers — the middlemen who supposedly negotiate drug prices — have become a massive corruption problem.
PBMs take kickbacks from pharmaceutical companies that “deceptively raise the cost of health insurance.” They’re supposed to negotiate lower prices; instead, they’ve created a system where everyone profits except patients.
Trump’s plan would end those kickbacks. The middlemen would have to actually deliver value or get out of the way.
The Democrats’ Shutdown
This plan arrives after Democrats shut down the government for weeks over Obamacare subsidies.
They wanted to continue enhanced subsidies that were first enacted during COVID through Biden’s $1.9 trillion spending bill. Those subsidies go to insurance companies, not citizens.
Democrats fought to keep money flowing to corporations. Trump is proposing to send it to people instead.
The contrast is clarifying.
CBO Scoring
According to the Congressional Budget Office, the plan’s cost-sharing reduction program would bring down health insurance premiums by at least 10 percent and save taxpayers at least $36 billion.
Lower premiums. Taxpayer savings. Money going to citizens instead of corporations.
That’s the trifecta Democrats claim to want but never deliver.
“Bigger Than Obamacare”
Then-Senator Mike Braun said in 2024 that codifying Trump’s healthcare price transparency rules would be “bigger than Obamacare.”
He might be right.
Obamacare expanded coverage but did nothing to control costs. Premiums skyrocketed. Deductibles became unaffordable. Americans had “insurance” they couldn’t actually use.
Trump’s approach attacks the cost problem directly. Lower drug prices through international parity. Direct subsidies to citizens. Transparency that forces competition.
If it works, it would actually make healthcare affordable — something Obamacare promised but never delivered.
Who Opposes This
Watch who comes out against the Great Healthcare Plan.
Insurance companies that profit from the current system.
Pharmaceutical companies charging Americans more than anyone else.
PBMs whose entire business model depends on opacity and kickbacks.
Democrats who claim to support lower drug prices but take millions from pharma lobbyists.
The opposition will tell you everything you need to know about who benefits from the status quo.
The Political Battle
Senate Democrats previously objected to cost-sharing reduction payments in the Big Beautiful Bill, claiming it violated the Byrd Rule.
They’ll find procedural objections to this plan too. They always do when reforms threaten their donor base.
But Trump is framing the issue clearly: money to corporations versus money to citizens. Insurance company profits versus patient choice. Hidden pricing versus transparency.
Those are winning arguments. Democrats will struggle to explain why they oppose sending subsidy money directly to Americans.
What Happens Next
The plan needs Congressional action to become law.
Republicans control both chambers. The policy substance is popular. The political framing favors Trump.
The question is whether enough Republicans will resist insurance and pharma lobbying to actually pass it.
Trump is betting Americans want lower prices more than corporations want higher profits.
Given what families are paying for healthcare, that seems like a safe bet.
The Great Healthcare Plan puts money in your pocket instead of insurance company coffers.
Now we’ll see if Congress has the courage to make it law.